These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 24480534)

  • 1. An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression.
    Kaialy W; Larhrib H; Chikwanha B; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Apr; 464(1-2):53-64. PubMed ID: 24480534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisolvent precipitation of novel xylitol-additive crystals to engineer tablets with improved pharmaceutical performance.
    Kaialy W; Maniruzzaman M; Shojaee S; Nokhodchi A
    Int J Pharm; 2014 Dec; 477(1-2):282-93. PubMed ID: 25447824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
    Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
    Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose.
    Kaerger JS; Edge S; Price R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):173-9. PubMed ID: 15158902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physico-mechanical and dissolution behaviours of ibuprofen crystals crystallized in the presence of various additives.
    Nokhodchi A; Amire O; Jelvehgari M
    Daru; 2010; 18(2):74-83. PubMed ID: 22615598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallization of paracetamol from ethanol-water solutions in the presence of polymers.
    Kachrimanis K; Malamataris S
    J Pharm Pharmacol; 1999 Nov; 51(11):1219-27. PubMed ID: 10632078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly compressible paracetamol: I: crystallization and characterization.
    Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Int J Pharm; 2000 Nov; 208(1-2):87-99. PubMed ID: 11064214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of additives on the growth and morphology of paracetamol (acetaminophen) crystals.
    Thompson C; Davies MC; Roberts CJ; Tendler SJ; Wilkinson MJ
    Int J Pharm; 2004 Aug; 280(1-2):137-50. PubMed ID: 15265554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compression behavior of orthorhombic paracetamol.
    Joiris E; Di Martino P; Berneron C; Guyot-Hermann AM; Guyot JC
    Pharm Res; 1998 Jul; 15(7):1122-30. PubMed ID: 9688070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol.
    Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Int J Pharm; 1999 Sep; 187(1):77-89. PubMed ID: 10502615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisolvent membrane crystallization of pharmaceutical compounds.
    Di Profio G; Stabile C; Caridi A; Curcio E; Drioli E
    J Pharm Sci; 2009 Dec; 98(12):4902-13. PubMed ID: 19655372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of additives like polymers and surfactants in the crystallization of mebendazole.
    Kumar S; Chawla G; Bansal AK
    Yakugaku Zasshi; 2008 Feb; 128(2):281-9. PubMed ID: 18239376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable carbamazepine colloidal systems using the cosolvent technique.
    Douroumis D; Fahr A
    Eur J Pharm Sci; 2007 Apr; 30(5):367-74. PubMed ID: 17234395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic control of inhalation microparticles prepared by crystallization.
    Murnane D; Marriott C; Martin GP
    Int J Pharm; 2008 Sep; 361(1-2):141-9. PubMed ID: 18582548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel polymorphic form of adefovir dipivoxil derived from polymer-directed crystallization.
    Lee MK; Lee H; Kim IW; Lee J
    Pharmazie; 2011 Oct; 66(10):766-70. PubMed ID: 22026158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
    Murnane D; Marriott C; Martin GP
    Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.